Medical Oncology, Hospital Universitario de Salamanca-IBSAL, Spain.
Medical Oncology, Hospital Universitario de Salamanca-IBSAL, España.
Rev Esp Enferm Dig. 2024 Aug;116(8):455-456. doi: 10.17235/reed.2023.9987/2023.
A 81-year-old woman with a history of mild chronic heart failure and invasive lobular breast carcinoma pT2N0M0 diagnosed in 2009 and treated by mastectomy, chemotherapy, radiotherapy and adjuvant endocrine therapy with letrozole until 2016. Since then the patient has been disease-free. She presented to the Emergency Room in April 2023 due to severe postprandial epigastric pain and a 7 kg weight loss in the last 3 months. Abdominal computed tomography was performed showing thickening of the gastric antrum and proximal duodenum walls, peritoneal implants and ascites that suggested primary gastric tumor or lymphoma as the first possibility. An endoscopic ultrasound was schedule, performing a biopsy of the gastric lesion and placing a Hot-Axios® stent. The sample showed infiltration by lobular breast carcinoma CK7 (+), CK20 (-), CDX2 (-), GATA3 (+) GCDFP15 (+) RE (+) RP (-) HER2 (-). Treatment with capecitabine was started, with which it continues currently.
一位 81 岁女性,既往有轻度慢性心力衰竭和浸润性小叶乳腺癌病史,2009 年诊断为 pT2N0M0,并接受了乳房切除术、化疗、放疗和辅助内分泌治疗(来曲唑)至 2016 年。此后,患者一直无病生存。她于 2023 年 4 月因严重餐后上腹痛和过去 3 个月体重减轻 7 公斤就诊于急诊。腹部计算机断层扫描显示胃窦和近端十二指肠壁增厚、腹膜种植和腹水,首先考虑原发性胃肿瘤或淋巴瘤。计划进行内镜超声检查,对胃病变进行活检并放置 Hot-Axios®支架。标本显示小叶乳腺癌浸润,CK7(+),CK20(-),CDX2(-),GATA3(+),GCDFP15(+),RE(+),RP(-),HER2(-)。开始使用卡培他滨治疗,目前仍在继续。